Developing a trace level GC-MS method for detecting methylhydrazine in an experimental drug substance.
Methylhydrazine (NH(2)NHCH(3), CAS 60-34-4) is a highly reactive reducing agent used as an intermediate for synthesizing an experimental drug substance. Methylhydrazine is a known mutagen, an animal carcinogen, and a suspected human carcinogen. A gas chromatography-mass spectrometry method was developed as a limit test method for analyzing trace levels of methylhydrazine in the experimental drug substance. The method utilizes acetone as a dissolving solvent for the drug substance and a derivatizing agent for methylhydrazine in the meantime, thus eliminating the need for post-derivatization sample clean-up prior to analysis. The gas chromatographic (direct injection) conditions provide good separation for the acetone-methylhydrazine derivative (acetone methylhydrazone) from matrix interference, and mass spectrometric detection (selected ion monitoring mode, m/z 86) allows sufficient sensitivity for detecting 1 part per million methylhydrazine relative to the drug substance.